Both in Pharmaceuticals
Milestone Pharmaceuticals vs Citius Oncology
Over the past year MIST returned −56.7% and CTOR returned −50.2%; their daily moves had a correlation of 0.17.
MIST −56.7% CTOR −50.2%Growth of $1, one year, split-adjusted
| Metric | MIST | CTOR |
|---|---|---|
| Price | $0.8657 | $1.01 |
| Market cap | $107.8M | $106.8M |
| Today | +5.57% | −3.81% |
| 1 month | −25.4% | +32.3% |
| 6 months | −27.3% | +62.9% |
| Year to date | −57.1% | +1.0% |
| 1 year | −57.4% | −50.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 94.3% | 67.1% |
| Net margin | −5118.8% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 46.0× | 15.0× |
| Net cash | $111.4M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 100.3% |
| Short % of float | 16.2% | 1.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).